EVOFEM BIOSCIENCES, INC. Repayments of Short-term Debt
EVOFEM BIOSCIENCES, INC. (EVFM) reported Repayments of Short-term Debt of $520.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2026-08-14
- EVOFEM BIOSCIENCES, INC. repayments of short-term debt for the quarter ending 2026-06-30 was $22.00K, a 91.13% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. repayments of short-term debt for the quarter ending 2026-03-31 was $498.00K, a 268.89% increase year-over-year.
- EVOFEM BIOSCIENCES, INC. repayments of short-term debt for the quarter ending 2025-12-31 was $278.00K, a 4.12% increase year-over-year.
- EVOFEM BIOSCIENCES, INC. repayments of short-term debt for the quarter ending 2025-09-30 was $244.00K, a 6.87% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. repayments of short-term debt for fiscal 2025 was $905.00K, a 15.73% increase from fiscal 2024.
- EVOFEM BIOSCIENCES, INC. repayments of short-term debt for fiscal 2024 was $782.00K, a 32.24% decline from fiscal 2023.
- EVOFEM BIOSCIENCES, INC. repayments of short-term debt for fiscal 2023 was $1.15M.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $520.00K 10-Q · filed 2026-08-14 | $798.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.04M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $498.00K 10-Q · filed 2026-05-15 | $776.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.02M derived: sum of 3 quarters · filed 2026-05-15 | $1.27M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $522.00K derived: sum of 2 quarters · filed 2026-03-11 | $770.00K derived: sum of 3 quarters · filed 2026-08-14 | $905.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $492.00K derived: sum of 2 quarters · filed 2026-08-14 | $627.00K 10-Q · filed 2025-11-13 | $894.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $383.00K 10-Q · filed 2026-08-14 | $650.00K derived: sum of 3 quarters · filed 2026-08-14 | $912.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $135.00K 10-Q · filed 2026-05-15 | $402.00K derived: sum of 2 quarters · filed 2026-05-15 | $664.00K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $529.00K derived: sum of 2 quarters · filed 2026-03-11 | $782.00K 10-K · filed 2026-03-11 | |
| 2024-09-30 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $515.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $253.00K 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $1.15M 10-K · filed 2025-03-24 |